Plasma from rheumatoid patients taking low dose methotrexate enhances platelet aggregation

Research Communications in Molecular Pathology and Pharmacology

Volumn 111, Issue 1-4, 2002, Pages 69-76

  Saeed, S A ^a   Gilani, A H ^a   Rasheed, H ^a   Bhatti, F N ^a   Atiq, M ^a   Qureshi, A ^c   Jafary, R ^b   Connor, J D ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b CIVIL HOSPITAL   (Pakistan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; DICLOFENAC; ETODOLAC; FLURBIPROFEN; INDOMETACIN; METHOTREXATE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE; VALERYL SALICYLATE;

ARTICLE; BLOOD DYSCRASIA; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MECHANISM; FEMALE; HUMAN; IC 50; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BLOOD; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METHOTREXATE; PLATELET AGGREGATION;

EID: 0141448897     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ali, A.A., Iqbal, M.P., Hussain, M.A., Mehboobali, N., Beg, J.A., Rahbar, M.H. (1998). Methotrexate in rheumatoid arthritis: a 2 years experience at a University hospital in Pakistan. J. Pak. Med. Assoc. 48, 3-6.
2. Crofford, A., Loubet-Lescoulie, P., Lambert, N., Yassine-Diab, B., Abbal, M., Mazieres, B., De Preval, C. and Contagrel, A. (1998). Anti-inflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expressions demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum. 41, 48-57.
3. Crofford, L.J., Oates, J.C., McCune, W.J., Gupta, S., Kaplan, M.J., Lawson, F.C., Morrow, J.D., McDonagh, K.T. and Schmaier, A.H. (2000). Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. Arthritis Rheum 43, 1891-1896.
4. Cronstein, B.N. Naime, D. and Ostad, E. (1993). The anti-inflammatory mechanisms of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92, 2675-82.
5. Franck, H., Rau, R. and Herborn, G. (1996). Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. Clin. Rheumatol. 15, 266-270.
6. Gordon, P., West, J., Jones, H. and Gibson, T. (2001). A 10 year prospective follow up of patients with rheumatoid arthritis 1986-96. J. Rheumatol. 28, 2409-15.
7. th Ed., Mc Graw-Hill, New York, pp 1880-1888.
8. Mello, S.B., Barros, D.M., Silva, A.S., Laurindo, I.M. and Novaes, G.S. (2000). Methotrexate as a preferential cyclooxgenase 2 inhibitor in whole blood of patients with rheumatoid arthritis. J Rheumatol. 39, 533-536.
9. Rudwaleit, M., Yin, Z., Siegert, S., Grolms, M., Rodbruch, A., Braun, J. and Sieper, J. (2000). Response to methotrexate in early rheumatoid arthritis is associated with a decrease of t cell derived tumor necrosis factor alpha, increase of interleukin-10, and predicted by the initial concentration of interleukin-4. Ann Rheum Dis. 59, 311-314.
10. Saeed, S.A., Shah, B.H., Khan, N. and Gilani, A.H. (1997). Synergistic interaction of calcium-ionophore, A-23187 and dopamine in human platelet aggregation. Med Sci Res. 25, 219-221.
11. Salaffi, F., Carotti, M., Sartini, A. and Cervini, C. (1995). A prospective study of the long-term efficacy and toxicity of low-dose methotrexate in rheumatoid arthritis. Clin Exp Rheumatol. 13, 23-28.
12. Seitz, M., Loetscher, P., Dewald, B., Towbin, H., Rordorf, C., Gallati, H., Baggiolini, M. and Gerber, N. J. (1995). Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol. 34, 602-609.
13. Smolenska, Z., Kaznouska, Z. Zarowny, D., Simmonds, H.A. and Solenski, R.T. (1999). Effect of methotrexate on blood purine and pyrimidine levels in-patients with rheumatoid arthritis. Rheumatology 38, 997-1002.
14. Van Ede, A.E., Laan, R.F., Blom, H.J., de Abreu, R.A. and van de Putte, L.B. (1998). Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin. Arthritis Rheum. 27, 277-92.
15. Weinblatt, M.E. (1995). Efficacy of methotrexate in rheumatoid arthritis. Br J Rheumatol. 34, 43-48.